Vijaypd Ceutical Limited
Fixed Price IPO · NSE
- Price band
- ₹35 - ₹35
- Lot size
- 4,000 shares
- Issue amount
- ₹19.25 cr
- Total subscription
- 1.43×
- Opens
- 29 Sept 2025
- Closes
- 1 Oct 2025
- Allotment
- 3 Oct 2025
- Listing
- 7 Oct 2025
Offer at a glance
Issue overview
- Issue size
- 55,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,40,000
- Fresh issue
- ₹19.25 cr
- Offer for sale
- ₹0 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,40,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 1,40,28,686
- Shares after issue
- 1,95,28,686
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 2 | 8,000 | ₹2,80,000 |
| HNI | 3 | 12,000 | ₹4,20,000 |
Share reservation
Subscription & GMP
Subscription by category
Reported 1 Oct 2025
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 0 |
| NIB | 0 | 111 |
| RETAIL | 326 | 290 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| RETAIL | 9.13 | 8.12 |
| NIB | 9.13 | 17.95 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 3.84 | 8.25 | 0.91 |
| ROE | 28.91 | 55.64 | 3.96 |
| ROCE | 17.3 | 14.61 | 8.9 |
| RONW | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 0 | 0 |
| POST IPO(PE) | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| MedPlus Health Services Limited | 249.42 | 840.55 | 2.00 | 103.63 | 3.32 | 3.37 |
| Vijaypd Ceutical Limited | NA | NA | 10.00 | 25.78 | 14.91 | 3.84 |
| Entero Healthcare Solutions Limited | 256.17 | 1129.7 | 10.00 | 379.33 | 1.17 | 4.41 |
Company information
Company profile
Incorporated in October 1971, Vijaypd Ceutical Limited is a pharmaceutical distributor that supplies a wide range of pharmaceutical products and consumer goods while offering comprehensive services. The company operates in various capacities, including as representatives, dealers, agents, stockists, suppliers, traders, and packers. It caters to the pharmaceutical, wellness, and FMCG sectors, offering a diverse portfolio that includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral products. Additionally, the company supplies vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items like soaps, sanitizers, and baby care products, as well as ayurvedic products, cosmetics, food items, dental products, and crude drugs. As of March 31, 2025, Vijaypd Ceutical Limited serves over 2,109 pharmacies, clinics, and nursing homes across four districts, spanning 20 locations. Its extensive distribution network connects with more than 170 healthcare product manufacturers, offering access to over 19,000 stock-keeping units (SKUs). This wide-ranging portfolio enables the company to effectively meet customer needs while maintaining high standards of quality and reliability in pharmaceutical supply. The company holds certifications from the FDA, FSSAI, and BMC, underscoring its commitment to regulatory compliance and quality assurance.
Strengths
- Strong Client Relationships – Focus on strengthening long-term client associations, enhancing customer loyalty and improving revenue stability.
- Broad Product Portfolio – Diverse and customized product offerings cater to a wide range of customer needs, establishing the company as a comprehensive solutions provider.
- Streamlined Supply Chain Management – Efficient procurement and logistics processes ensure timely delivery, cost optimization, and operational efficiency.
Risk factors
- API & Excipients Expansion Risk: Entry into new segments exposes the company to operational and financial challenges.
- Product Development & Approval Risk: Regulatory delays or market rejection may lead to unsuccessful product launches.
- Customer & Market Concentration Risk: Heavy reliance on limited clients or markets could impact revenue and profitability, especially in the initial phase.
Promoters
Samit Madhukar Shah
Bhavin Dhirendra Shah
Rahul Dhirendra Shah
Narendra Nagindas Shah
Dina Madhukar Shah
Hemanti Jitendra Shah
Registrar & documents
Lead manager
Smart Horizon Capital Advisors Private Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
A/1, 1st Floor Devraj Premises CHSL, Goregaon West Mumbai, Maharashtra, 400062
+91 9820917040
[email protected]Company website ↗Understanding VIJAYPD IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.